![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Springe zu: 2022
Anzahl der Publikationen: 2
2022
Simpson, Eric L.; Wollenberg, Andreas; Soong, Weily; Steffensen, Louise Abildgaard; Kurbasic, Azra; Schneider, Shannon; Zoidis, John und Silverberg, Jonathan I.
(2022):
Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3).
In: Annals of Allergy Asthma & Immunology, Bd. 129, Nr. 5: S. 592-604
Paller, Amy S.; Simpson, Eric L.; Siegfried, Elaine C.; Cork, Michael J.; Wollenberg, Andreas; Arkwright, Peter D.; Soong, Weily; Gonzalez, Mercedes E.; Schneider, Lynda C.; Sidbury, Robert; Lockshin, Benjamin; Meltzer, Steven; Wang, Zhixiao; Mannent, Leda P.; Amin, Nikhil; Sun, Yiping; Laws, Elizabeth; Akinlade, Bolanle; Dillon, Myles; Kosloski, Matthew P.; Kamal, Mohamed A.; Dubost-Brama, Ariane; Patel, Naimish; Weinreich, David M.; Yancopoulos, George D.; O'Malley, John T. und Bansal, Ashish
(2022):
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
In: Lancet, Bd. 400, Nr. 10356: S. 908-919